Instead, our discovery that ETV6 constrains EWS–FLI activity highlights a distinct, but equally central, epigenetic mechanism that drives tumour growth and reveals an unexpected contrast between Ewing sarcoma and other paediatric tumours in which CRCs are functionally dominant. This evidence concerns the gene FLII and neoplasm.